Data from a post-hoc analysis of the Phase 3 clinical trial of Stelara® (ustekinumab) for treatment of people with moderate-to-severe lupus further validates the value of the Lupus Foundation of ...

Assessing disease activity is an important part of daily practice, clinical trials and other lupus – related research. There are several tools that have been developed, but none is perfect. Each has ...